On Tuesday, Standard Pacific Corp. (NYSE:SPF)’s shares inclined 0.68% to $8.91.
Standard Pacific Corp. (SPF) will release its 2015 second quarter results after the market close of the NYSE on Thursday, July 30, 2015. In conjunction with the earnings release, the Company will host a conference call and broadcast a slide show and audio presentation over the internet on Friday, July 31, 2015, at 12:00 p.m. Eastern time.
Standard Pacific Corp. operates as a builder of single-family attached and detached homes in the United States. It constructs homes for various homebuyers primarily move-up buyers in metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, and Colorado. The company also provides mortgage financing services to its homebuyers; and title examination services to its Texas and Florida homebuyers.
Veeva Systems Inc (NYSE:VEEV)’s shares gained 0.09% to $28.03.
Veeva Systems Inc (VEEV) declared a planned partnership to accelerate the life sciences industry’s move to more customer-centric engagement. The companies are joining forces to deliver innovation in customer data and data science for better marketing and sales effectiveness across all channels.
The Veeva and ZS planned partnership will initially focus in two key areas ripe for innovation:
Data Science - ZS has become a Veeva Data Science partner. Powered by data science in ZS’s Suggestion Engine, Veeva CRM Suggestions recommends the best actions and channels to reps to improve sales effectiveness. With this partnership, companies can now leverage ZS’ leading Orchestrator Rep solution to seamlessly deliver recommendations right within Veeva CRM.
Customer Data - ZS has joined the Veeva OpenData Partner Program allowing fast, simple integration of Veeva OpenData healthcare provider, healthcare organization, and affiliations data with ZS’ data solutions.
Veeva Systems Inc. provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. Its solutions comprise Veeva CRM, a customer relationship administration solution that allows pharmaceutical and biotechnology companies to market and sell compliantly to physicians, other healthcare professionals, and healthcare organizations through multiple touch points, counting face-to-face, email, and online; and Veeva Vault, a cloud-based content administration and partnership solution for its customers to manage content-centric processes in various departments within a life sciences company, counting clinical trials, regulatory submissions, quality administration, manufacturing, medical, sales, and marketing.
At the end of Tuesday’s trade, Wright Medical Group Inc (NASDAQ:WMGI)‘s shares surged 0.19% to $26.26.
Wright Medical Group, Inc. (WMGI) and Tornier N.V. (TRNX) declared that all proposals related to the combination of Wright and Tornier were approved by both Wright’s and Tornier’s shareholders.
Based on final vote results for Wright, the proposal to adopt the merger agreement and approve the merger was approved by shareholders owning 97.72 percent of the shares voted at the meeting and 84.36 percent of the outstanding Wright shares as of the record date. The final vote results for all proposals will be comprised of in a current report on Form 8-K to be filed by Wright with the Securities and Exchange Commission.
Based on final vote results for Tornier, the proposal to adopt the merger agreement and approve the merger was approved by shareholders owning 99.36 percent of the shares voted at the meeting and 80.08 percent of the outstanding Tornier shares as of the record date. In addition, the proposals to appoint the combined company board of directors and change the company name to Wright Medical Group N.V. were approved. The final vote results for all proposals will be comprised of in a current report on Form 8-K to be filed by Tornier with the Securities and Exchange Commission.
Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients lifestyles worldwide. The company offers products that are used primarily in foot and ankle repair, upper extremity products, and biologics products. Its extremity hardware products comprise implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow, and shoulder.
Simon Property Group Inc (NYSE:SPG), ended its Tuesday’s trading session with 1.18% gain, and closed at $173.02.
Simon®, the global leader in retail real estate and omni-channel retail, today announced the winners of the inaugural ‘Simon Launch’ retail startup competition.
The winning startups, selected from more than 300 applications, are:
- LimeSpot Solutions, a personalization engine for ecommerce that utilizes the power of advanced machine learning, social network profiles/history, and behavioral analysis.
- Rank & Style, simplifying shopping by bringing consumers unbiased, data-driven ‘Top Ten’ lists of the best fashion and beauty products.
- SKU IQ, technology that syncs real-time inventory across in-store point of sale systems, warehouse management systems, and e-commerce platforms and marketplaces.
Winners of the ‘Simon Launch’ competition have received a co-investment from Simon Venture Group and Plug and Play, a global investor and technology accelerator, and have been accepted into Plug and Play’s Retail Accelerator Program in Silicon Valley.
Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, administration, and development of properties. It primarily invests in regional malls, premium outlets, mills, and community/lifestyle centers to create its portfolio. Simon Property Group, Inc. was founded in 1960 and is based in Indianapolis, Indiana, with additional office in New York, New York.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
